Combination of Two Osteopathic Techniques for the Hamstring's Stretching Capacity in Basketball Female Players

April 26, 2024 updated by: Natália Maria Oliveira Campelo

Effect of the Muscular Energy Technique With the 4th Ventricle Technique on the Range of Motion of the Hamstring Muscles in Female Basketball Players: RCT

It is known that there are studies that prove the effectiveness of muscle energy techniques and the fourth ventricle technique separately, however, information is scarce regarding the combination of the two and their effectiveness in the population. The aim of this randomized controlled study is to compare the immediate effects of the techniques compared to the muscle energy technique alone in female basketball players.

Study Overview

Detailed Description

The muscular energy technique (MET) is a manual therapy technique that uses isometric contractions with the aim of increasing the extensibility of the muscle group, as well as promoting lymphatic and venous circulation. The fourth ventricle technique (CV-four) plays an amplifying role in the movement of tissues and fluids, restoring the flexibility of the autonomous response. For the MET, the researcher adopted a position homolateral to the dominant limb, contacting the lower limb with the caudal hand in the region of the malleoli. He then helped the participant to perform the movement, which consisted of flexion of the hip and extension of the knee passively until the motor barrier was reached, after which she was instructed to perform an isometric contraction of the hamstring. A total of three contractions of seven seconds with an interval of two to three seconds were requested, using approximately twenty per cent of their maximum force, and gaining a new motor barrier between each series, for a total of three series. For the CV-four technique, the researcher adopted a seated position and laterally contacted the scaly portion of the occiput, bringing it closer to the posterior convexity of the occiput, bringing the skull into extension, changing the compression movement with decompression, until three minutes had elapsed. At all stages of the session, the participant was positioned in the supine position, with the upper limbs alongside the body and the neck in a neutral position. All the participants in the study underwent an initial and final assessment protocol to determine their range of motion (ROM).

Study Type

Interventional

Enrollment (Estimated)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Natália MO Campelo, PhD
  • Phone Number: +35122 206 1000
  • Email: nmc@ess.ipp.pt

Study Locations

      • Porto, Portugal, 4200-072
        • Escola Superior de Saúde do Porto
        • Principal Investigator:
          • Natália MO Campelo
        • Contact:
          • Natália Campelo
          • Phone Number: +35122 206 1000
          • Email: nmc@ess.ipp.pt

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Over 18 years old
  • Female
  • Playing federated basketball
  • Signature of informed consent documents

Exclusion Criteria:

  • Surgical intervention/trauma in the areas of activity (cervical-cranial and lower limb)
  • Exposure to medicinal therapy
  • Participants with hypertension
  • Participants at risk of cerebral hemorrhage (e.g. aneurysm)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control Group
After completing an individual questionnaire and giving informed consent, a placebo technique was performed, consisting only of contact in the area of the participant's shoulders.

The participant was in a supine position, with her upper limbs at her sides and her neck in a neutral position.

The researcher sat in a cephalic position, making contact with the participant's shoulders, without any movement, until 5 minutes had elapsed.

Experimental: Experimental group MET
After completing an individual questionnaire and giving informed consent, the muscle energy technique was performed on the dominant hamstring muscle.

The participant was in a supine position, with her upper limbs alongside her body and her neck in a neutral position.

The researcher adopted a position homolateral to the dominant limb, contacting the lower limb with the caudal hand in the region of the malleoli. He then helped the participant to perform the movement, which consisted of flexing the hip and extending the knee passively until the motor barrier was reached, and instructed her to perform an isometric contraction of the hamstrings. She was asked to perform three 7-second contractions with a 2 to 3-second interval, using approximately 20% of her maximum strength, gaining a new motor barrier between each set, for a total of three sets.

Experimental: Experimental group CV-4 and MET
After completing an individual questionnaire and giving informed consent, the 4th ventricle technique (CV-4) was performed, followed by the muscle energy technique on the dominant hamstring muscle.

The participant was in a supine position, with her upper limbs alongside her body and her neck in a neutral position.

For CV-4, the researcher contacted the squamous portion of the occiput laterally, bringing it close to the posterior convexity of the occiput, bringing the skull into extension, changing the compression movement with decompression, until 3 minutes had elapsed.

For the MET, the researcher adopted a position homolateral to the dominant limb, contacting the lower limb with the caudal hand in the region of the malleoli. She then helped the participant to perform the movement, which consisted of flexing the hip and extending the knee passively to the motor barrier, having been instructed to perform an isometric contraction of the hamstring. A total of 3 7-second contractions with a 2-3 second interval were requested, using approximately 20% of her maximum strength, and with a new motor barrier being gained between each series, for a total of 3 series.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Altered range of motion of the hamstring muscles.
Time Frame: 10 minutes after intervention.
The universal goniometer is a tool used to assess joint ROM.
10 minutes after intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Natália MO Campelo, PhD, Escola Superior de Saúde do Politecnico do Porto

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 1, 2024

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

April 5, 2024

First Submitted That Met QC Criteria

April 5, 2024

First Posted (Actual)

April 10, 2024

Study Record Updates

Last Update Posted (Estimated)

April 30, 2024

Last Update Submitted That Met QC Criteria

April 26, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Simulated technique

3
Subscribe